Life Sciences
Huma's virtual clinical trial solution connects trial participants, investigators, and research teams. It accelerates recruitment while driving participant engagement and protocol adherence. Huma’s technology for clinical trials reduces participant burden and improves the visibility of patient-generated data collected in the real-life setting.
The Current Situation
One of the most important parts of clinical research is the patient’s ability to participate. By making research more human-centric and giving participants the ability to virtually access and actively engage in trials, we can lower the burden on participants, and increase engagement and retention rates.
Our offering
We have integrated a portfolio of over 400 external wearables and connected devices to enable seamless data capture. We have established partnerships with device distributors.
A web-based dashboard providing insight into participant data generated from the patient app. Allows remote monitoring of participants through their provided device data/PROMs, and incorporates telemedicine for direct communication with participants.
Device-agnostic app that enables remote participant data capture, and houses educational content for improved participant engagement. Huma's app can be configured from a portfolio of 100+ modules to meet the needs of your clinical trial protocol.
Our offering
Engaging device-agnostic app:
Remotely collects data, reducing the number of site visits, and lowering the burden on participants and their families.
Guides patients on using medication, and provides reminders on when to take/record medication use at home.
Delivers high protocol adherence, helping participants/carers know what is expected of them and when.
Includes integrated sensors and can connect to 400+ devices.
Remote data monitoring platform:
Provides real-time visibility of patient data.
Includes telemedicine for easy communication with participants/patients for remote visits/assessments.
Provides alerts & thresholds to help easily identify patients that require support or urgent follow-up.
Visualises individual patient adherence to study schedule.
Remote study monitoring platform:
Improves adherence to clinical trial protocols, reducing missing data.
Improves participant engagement and retention, reducing drop out rates.
Provides visibility of usability metrics, identifying those participants that require the most support.
Provides access to de-identified and structured data.
Cloud agnostic, rapidly deployable, modular solution.
Engaging device-agnostic app:
Remotely collects data, reducing the number of site visits, and lowering the burden on participants and their families.
Guides patients on using medication, and provides reminders on when to take/record medication use at home.
Delivers high protocol adherence, helping participants/carers know what is expected of them and when.
Includes integrated sensors and can connect to 400+ devices.
Remote data monitoring platform:
Provides real-time visibility of patient data.
Includes telemedicine for easy communication with participants/patients for remote visits/assessments.
Provides alerts & thresholds to help easily identify patients that require support or urgent follow-up.
Visualises individual patient adherence to study schedule.
Remote study monitoring platform:
Improves adherence to clinical trial protocols, reducing missing data.
Improves participant engagement and retention, reducing drop out rates.
Provides visibility of usability metrics, identifying those participants that require the most support.
Provides access to de-identified and structured data.
Cloud agnostic, rapidly deployable, modular solution.
How it works
Enables sponsors to access a wider population, and pre-screen patients to identify those likely to meet the study eligibility criteria, reducing screen failure rates.
In-app reminders and key actions ensure participants know what is expected of them and when, which improves protocol compliance and reducing missed visits.
Huma’s telemedicine solution enables investigators to promptly support participants remotely, reducing clinical site visits and improving the participant experience.
Targeted information, ensuring clear expectations are communicated at the start, and patients are supported at every milestone and feel valued with regular study updates.
In-built e-consent functionality, that supports remote on-boarding and allows patients to be fully informed prior to trial initiation
(Coming soon).
Guides participants on using medication, and provides reminders on when to take/record medication use at home or return to the clinic for their treatment.
Huma has an extensive library of core and 3rd-party modules to track and monitor participants e.g. ePROs, eDiary, ePerfOs, activity tracking.
Device agnostic with the ability to capture data from 400+ connected devices, wearables, and phone sensors
Enables sponsors to access a wider population, and pre-screen patients to identify those likely to meet the study eligibility criteria, reducing screen failure rates.
In-built e-consent functionality, that supports remote on-boarding and allows patients to be fully informed prior to trial initiation
(Coming soon).
In-app reminders and key actions ensure participants know what is expected of them and when, which improves protocol compliance and reducing missed visits.
Guides participants on using medication, and provides reminders on when to take/record medication use at home or return to the clinic for their treatment.
Huma’s telemedicine solution enables investigators to promptly support participants remotely, reducing clinical site visits and improving the participant experience.
Huma has an extensive library of core and 3rd-party modules to track and monitor participants e.g. ePROs, eDiary, ePerfOs, activity tracking.
Targeted information, ensuring clear expectations are communicated at the start, and patients are supported at every milestone and feel valued with regular study updates.
Device agnostic with the ability to capture data from 400+ connected devices, wearables, and phone sensors
How it works
A comprehensive platform to collect high frequency everyday health data from sensors, devices and questionnaires.
One of the benefits of virtual clinical trials is the integration with EDC systems to combine real-life data with other clinical trial data.
Remote data visualised in a customisable dashboard, enabling real-time interrogation and analysis of data to discover insights.
Why Huma?
Medical device grade platform built under a Quality Management System compliant with global security, privacy and regulatory requirements.
Deployments with top 10 pharma companies, national governments, major healthcare providers and leading research institutions.
Cloud agnostic platform that is ready to be deployed on any infrastructure and in any language.
Our platform and captured data can be efficiently transferred and integrated with other clinical data sources, and platforms.
Digital biomarker solutions available on both iOS and Android, and can integrate and gather data from 400+ wearables devices.
Engaging experience for patients and trial participants, achieving high adherence rates.
250,000 modules already completed by participants so far.
Customisable dashboards provide real-time insights that help proactively monitor patients, manage patient care, and improve adherence.
Medical device grade platform built under a Quality Management System compliant with global security, privacy and regulatory requirements.
Deployments with top 10 pharma companies, national governments, major healthcare providers and leading research institutions.
Cloud agnostic platform that is ready to be deployed on any infrastructure and in any language.
Our platform and captured data can be efficiently transferred and integrated with other clinical data sources, and platforms.
Digital biomarker solutions available on both iOS and Android, and can integrate and gather data from 400+ wearables devices.
Engaging experience for patients and trial participants, achieving high adherence rates.
250,000 modules already completed by participants so far.
Customisable dashboards provide real-time insights that help proactively monitor patients, manage patient care, and improve adherence.å
Why Huma
Our platform gives life science companies the opportunity to build a longitudinal relationship with a patient population.
From sending out updates to participants who have been involved in studies (e.g. published results and regulatory approvals), to staying in contact with participants for follow-up studies (e.g. market research and RWE studies), Huma's preventative health and digital solutions make research more human-centric.
Recruited several thousand
participants within weeks
Case study
Huma partnered with the longitudinal Fenland cohort study and the Medical Research Council (MRC) Epidemiology Unit, University of Cambridge to understand the progression of and build early predictive models of presymptomatic COVID-19 infection.
The study involves 12,435 participants, with 15 years of existing data. The aim of the collaboration is to create a joint analytics dataset for digital biomarker discovery.
Case study
Huma is currently working with Bayer, Stanford Medicine and the Stanford Center for Digital Health (CDH) to validate an approach to decentralise the clinical trial experience for patient participants with atrial fibrillation. The study aims to prove the feasibility, acceptability, and best practices that can achieve high compliance, quality, and scientifically sound fully remote clinical trials.
This 6-month Decentralised Clinical Trial (DCT) will utilise Huma’s remote data collection platform to monitor medication adherence, conduct remote surveys and televisits, send information and reminders to patients, and track key disease symptoms by connecting to electrocardiogram (ECG) and blood pressure (BP) devices.
Went from signature to the study
going live in 6.5 weeks
Clinical trial delays: America’s patient recruitment dilemma. (2012) https://www.clinicaltrialsarena.com/analysis/featureclinical-trial-patient-recruitment/
Perceptions & Insights Study: The Participation Decision-Making Process. The Center for Information and Study on Clinical Research Participation (CISCRP) (2017) https://www.ciscrp.org/wp-content/uploads/2019/06/2017-CISCRP-Perceptions-and-Insights-Study-Decision-Making-Process.pdf
Why clinical trials are terminated. Pak, Theodore R., Rodriguez, Maria D., Roth, Frederick P. biorxiv.org/content/10.1101/021543v1
Differential dropout and bias in randomised controlled trials: when it matters and when it may not. Bell, Melanie L., Kenward, Michael G., Fairclough, Diane L., and Horton, Nicholas J. (2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4688419/
Smart Medication Adherence Monitoring in Clinical Drug Trials: A Prerequisite for Personalised Medicine? NCBI. Zijp, Tanja R., Mol, Peter G.M., Touw, Daan J., and van Boven, Job F.M. (2019) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833361/